Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nasrien Ezzeldin Ibrahim, M.D.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. McCarthy CP, Neumann JT, Michelhaugh SA, Ibrahim NE, Gaggin HK, Sörensen NA, Schäefer S, Zeller T, Magaret CA, Barnes G, Rhyne RF, Westermann D, Januzzi JL. Derivation and External Validation of a High-Sensitivity Cardiac Troponin-Based Proteomic Model to Predict the Presence of Obstructive Coronary Artery Disease. J Am Heart Assoc. 2020 Aug 18; 9(16):e017221. PMID: 32757795.
    Citations:    
  2. Murphy SP, Ibrahim NE, Januzzi JL. Heart Failure With Reduced Ejection Fraction: A Review. JAMA. 2020 Aug 04; 324(5):488-504. PMID: 32749493.
    Citations:    
  3. Michelhaugh SA, Camacho A, Ibrahim NE, Gaggin H, D'Alessandro D, Coglianese E, Lewis GD, Januzzi JL. Proteomic Signatures During Treatment in Different Stages of Heart Failure. Circ Heart Fail. 2020 Aug; 13(8):e006794. PMID: 32809875.
    Citations:    
  4. Januzzi JL, Ibrahim NE. The Need to Innovate and Accelerate Clinical Trial Performance: BeAT the Clock. J Am Coll Cardiol. 2020 Jul 07; 76(1):14-16. PMID: 32616157.
    Citations:    
  5. Moonsamy P, Axtell AL, Ibrahim NE, Funamoto M, Tolis G, Lewis GD, D'Alessandro DA, Villavicencio MA. Survival After Heart Transplantation in Patients Bridged With Mechanical Circulatory Support. J Am Coll Cardiol. 2020 Jun 16; 75(23):2892-2905. PMID: 32527398.
    Citations:    
  6. Ibrahim NE, Afilalo M, Chen-Tournoux A, Christenson RH, Gaggin HK, Hollander JE, Kastner P, Levy PD, Mang A, Masson S, Nagurney JT, Nowak RM, Pang PS, Peacock WF, Dipl-Stat VR, Walters EL, Januzzi JL. Diagnostic and Prognostic Utilities of Insulin-Like Growth Factor Binding Protein-7 in Patients With Dyspnea. JACC Heart Fail. 2020 May; 8(5):415-422. PMID: 32354416.
    Citations:    
  7. Ibrahim NE, Burnett JC, Butler J, Camacho A, Felker GM, Fiuzat M, O'Connor C, Solomon SD, Vaduganathan M, Zile MR, Januzzi JL. Natriuretic Peptides as Inclusion Criteria in Clinical Trials: A JACC: Heart Failure Position Paper. JACC Heart Fail. 2020 May; 8(5):347-358. PMID: 32171762.
    Citations:    
  8. Revuelta-López E, Núñez J, Gastelurrutia P, Cediel G, Januzzi JL, Ibrahim NE, Emdin M, VanKimmenade R, Pascual-Figal D, Núñez E, Gommans F, Lupón J, Bayés-Genís A. Neprilysin inhibition, endorphin dynamics, and early symptomatic improvement in heart failure: a pilot study. ESC Heart Fail. 2020 Apr; 7(2):559-566. PMID: 32045114.
    Citations:    
  9. Hayek SS, Leaf DE, Samman Tahhan A, Raad M, Sharma S, Waikar SS, Sever S, Camacho A, Wang X, Dande RR, Ibrahim NE, Baron RM, Altintas MM, Wei C, Sheikh-Hamad D, Pan JS, Holliday MW, Januzzi JL, Weisbord SD, Quyyumi AA, Reiser J. Soluble Urokinase Receptor and Acute Kidney Injury. N Engl J Med. 2020 01 30; 382(5):416-426. PMID: 31995687.
    Citations:    
  10. Raber I, McCarthy CP, Al Rifai M, Vaduganathan M, Michos ED, Wood MJ, Smyth YM, Ibrahim NE, DeFaria Yeh D, Asnani A, Mehran R, McEvoy JW. Gender differences in industry payments among cardiologists. Am Heart J. 2020 05; 223:123-131. PMID: 31926591.
    Citations:    
  11. Januzzi JL, Ibrahim NE. It is time for consistency in the use of biomarkers in heart failure clinical trials. Eur J Heart Fail. 2020 01; 22(1):90-91. PMID: 31797511.
    Citations:    
  12. Huffman JC, Massey CN, Chung WJ, Feig EH, Ibrahim NE, Celano CM. The case for targeted mid-life interventions to prevent cardiovascular disease. Acta Cardiol. 2019 Sep 17; 1-3. PMID: 31526305.
    Citations:    
  13. Bethea ED, Gaj K, Gustafson JL, Axtell A, Lebeis T, Schoenike M, Turvey K, Coglianese E, Thomas S, Newton-Cheh C, Ibrahim N, Carlson W, Ho JE, Shah R, Nayor M, Gift T, Shao S, Dugal A, Markmann J, Elias N, Yeh H, Andersson K, Pratt D, Bhan I, Safa K, Fishman J, Kotton C, Myoung P, Villavicencio MA, D'Alessandro D, Chung RT, Lewis GD. Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study. Lancet Gastroenterol Hepatol. 2019 10; 4(10):771-780. PMID: 31353243.
    Citations:    
  14. Ibrahim NE, Song Y, Cannon CP, Doros G, Russo P, Ponirakis A, Alexanian C, Januzzi JL. Heart failure with mid-range ejection fraction: characterization of patients from the PINNACLE Registry®. ESC Heart Fail. 2019 08; 6(4):784-792. PMID: 31268631.
    Citations:    
  15. Ibrahim NE, Song Y, Cannon CP, Doros G, Russo P, Ponirakis A, Alexanian C, Januzzi JL. Alteration of medical therapy in patients with heart failure relative to change in symptom severity. ESC Heart Fail. 2019 10; 6(5):1085-1087. PMID: 31268222.
    Citations:    
  16. McCarthy CP, Shrestha S, Ibrahim N, van Kimmenade RRJ, Gaggin HK, Mukai R, Magaret C, Barnes G, Rhyne R, Garasic JM, Januzzi JL. Performance of a clinical/proteomic panel to predict obstructive peripheral artery disease in patients with and without diabetes mellitus. Open Heart. 2019; 6(1):e000955. PMID: 31217993.
    Citations:    
  17. Natarajan P, Collier TS, Jin Z, Lyass A, Li Y, Ibrahim NE, Mukai R, McCarthy CP, Massaro JM, D'Agostino RB, Gaggin HK, Bystrom C, Penn MS, Januzzi JL. Association of an HDL Apolipoproteomic Score With Coronary Atherosclerosis and Cardiovascular Death. J Am Coll Cardiol. 2019 05 07; 73(17):2135-2145. PMID: 31047001.
    Citations:    
  18. Ibrahim NE, McCarthy CP, Shrestha S, Gaggin HK, Mukai R, Szymonifka J, Apple FS, Burnett JC, Iyer S, Januzzi JL. Effect of Neprilysin Inhibition on Various Natriuretic Peptide Assays. J Am Coll Cardiol. 2019 03 26; 73(11):1273-1284. PMID: 30898202.
    Citations:    
  19. Ibrahim NE, McCarthy CP, Shrestha S, Gaggin HK, Mukai R, Magaret CA, Rhyne RF, Januzzi JL. A clinical, proteomics, and artificial intelligence-driven model to predict acute kidney injury in patients undergoing coronary angiography. Clin Cardiol. 2019 Feb; 42(2):292-298. PMID: 30582197.
    Citations:    Fields:    
  20. Ibrahim NE, Gaggin HK, Turchin A, Patel HK, Song Y, Trebnick A, Doros G, Maya JF, Cannon CP, Januzzi JL. Heart rate, beta-blocker use, and outcomes of heart failure with reduced ejection fraction. Eur Heart J Cardiovasc Pharmacother. 2019 01 01; 5(1):3-11. PMID: 29490032.
    Citations: 1     Fields:    
  21. Ibrahim NE, McCarthy CP, Shrestha S, Lyass A, Li Y, Gaggin HK, Simon ML, Massaro JM, D'Agostino RB, Garasic JM, van Kimmenade RR, Januzzi JL. Blood kidney injury molecule-1 predicts short and longer term kidney outcomes in patients undergoing diagnostic coronary and/or peripheral angiography-Results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) study. Am Heart J. 2019 03; 209:36-46. PMID: 30641399.
    Citations:    Fields:    
  22. Elmariah S, McCarthy C, Ibrahim N, Furman D, Mukai R, Magaret C, Rhyne R, Barnes G, van Kimmenade RRJ, Januzzi JL. Multiple biomarker panel to screen for severe aortic stenosis: results from the CASABLANCA study. Open Heart. 2018; 5(2):e000916. PMID: 30487984.
    Citations:    
  23. Huffman JC, Smith DM, Ibrahim NE, Duque L, Moskowitz JT, Celano CM. Using mHealth interventions to promote cardiovascular health. Acta Cardiol. 2019 Aug; 74(4):283-285. PMID: 30328777.
    Citations:    Fields:    
  24. Crousillat DR, Ibrahim NE. Sex Differences in the Management of Advanced Heart Failure. Curr Treat Options Cardiovasc Med. 2018 Sep 21; 20(11):88. PMID: 30242521.
    Citations:    
  25. Ibrahim NE, Gupta R, Lyass A, Li Y, Shrestha S, McCarthy CP, Gaggin HK, van Kimmenade RRJ, Massaro JM, D'Agostino RB, Januzzi JL. Endothelin-1 Measurement in Patients Undergoing Diagnostic Coronary Angiography-Results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) Study. Clin Chem. 2018 11; 64(11):1617-1625. PMID: 30213784.
    Citations:    Fields:    
  26. Ibrahim NE, Januzzi JL. Established and Emerging Roles of Biomarkers in Heart Failure. Circ Res. 2018 08 17; 123(5):614-629. PMID: 30355136.
    Citations:    Fields:    
  27. Jefferies JL, Ibrahim NE. Are Guidelines Merely Suggestions? J Am Coll Cardiol. 2018 07 24; 72(4):367-369. PMID: 30025571.
    Citations:    Fields:    
  28. McCarthy CP, Ibrahim NE, van Kimmenade RRJ, Gaggin HK, Simon ML, Gandhi P, Kelly N, Motiwala SR, Mukai R, Magaret CA, Barnes G, Rhyne RF, Garasic JM, Januzzi JL. A clinical and proteomics approach to predict the presence of obstructive peripheral arterial disease: From the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) Study. Clin Cardiol. 2018 Jul; 41(7):903-909. PMID: 29876944.
    Citations:    Fields:    Translation:Humans
  29. Ibrahim NE, Januzzi JL. The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) Study. Curr Heart Fail Rep. 2018 04; 15(2):37-43. PMID: 29468530.
    Citations:    Fields:    Translation:Humans
  30. McCarthy CP, Ibrahim NE, Lyass A, Li Y, Gaggin HK, Simon ML, Mukai R, Gandhi P, Kelly N, Motiwala SR, van Kimmenade RRJ, Massaro JM, D'Agostino RB, Januzzi JL. Single-Molecule Counting of High-Sensitivity Troponin I in Patients Referred for Diagnostic Angiography: Results From the CASABLANCA (Catheter Sampled Blood Archive in Cardiovascular Diseases) Study. J Am Heart Assoc. 2018 03 08; 7(6). PMID: 29519811.
    Citations:    Fields:    
  31. Ibrahim NE, Song Y, Cannon CP, Doros G, Trebnick A, Russo P, Ponirakis A, Alexanian C, Januzzi JL. Retraction notice to Addition or removal of guideline directed medical therapy in ambulatory patients with heart failure with reduced ejection fraction relative to change in symptom severity: An analysis from the PINNACLE (Practice Innovation and Clinical Excellence) Registry® [International Journal of Cardiology 254 (2018) 222-223]. Int J Cardiol. 2018 03 01; 254:R1. PMID: 29752128.
    Citations:    Fields:    
  32. Ibrahim NE, Lyass A, Gaggin HK, Liu Y, van Kimmenade RRJ, Motiwala SR, Kelly NP, Gandhi PU, Simon ML, Belcher AM, Harisiades JE, Massaro JM, D'Agostino RB, Januzzi JL. Predicting new-onset HF in patients undergoing coronary or peripheral angiography: results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) study. ESC Heart Fail. 2018 06; 5(3):240-248. PMID: 29424480.
    Citations:    Fields:    Translation:Humans
  33. Ibrahim NE, Song Y, Cannon CP, Doros G, Trebnick A, Russo P, Ponirakis A, Alexanian C, Januzzi JL. Addition or removal of guideline directed medical therapy in ambulatory patients with heart failure with reduced ejection fraction relative to change in symptom severity: An analysis from the PINNACLE (Practice Innovation and Clinical Excellence) Registry®. Int J Cardiol. 2018 03 01; 254:222-223. PMID: 29407094.
    Citations:    Fields:    
  34. Yancy CW, Januzzi JL, Allen LA, Butler J, Davis LL, Fonarow GC, Ibrahim NE, Jessup M, Lindenfeld J, Maddox TM, Masoudi FA, Motiwala SR, Patterson JH, Walsh MN, Wasserman A. 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol. 2018 01 16; 71(2):201-230. PMID: 29277252.
    Citations: 8     Fields:    
  35. Ibrahim NE, Januzzi JL, Rabideau DJ, Gandhi PU, Gaggin HK. Serial Heart Rates, Guideline-Directed Beta Blocker Use, and Outcomes in Patients With Chronic Heart Failure With Reduced Ejection Fraction. Am J Cardiol. 2017 Sep 01; 120(5):803-808. PMID: 28728744.
    Citations: 1     Fields:    Translation:Humans
  36. McCarthy CP, van Kimmenade RRJ, Gaggin HK, Simon ML, Ibrahim NE, Gandhi P, Kelly N, Motiwala SR, Belcher AM, Harisiades J, Magaret CA, Rhyne RF, Januzzi JL. Usefulness of Multiple Biomarkers for Predicting Incident Major Adverse Cardiac Events in Patients Who Underwent Diagnostic Coronary Angiography (from the Catheter Sampled Blood Archive in Cardiovascular Diseases [CASABLANCA] Study). Am J Cardiol. 2017 07 01; 120(1):25-32. PMID: 28487034.
    Citations: 2     Fields:    Translation:Humans
  37. Ibrahim NE, Januzzi JL, Magaret CA, Gaggin HK, Rhyne RF, Gandhi PU, Kelly N, Simon ML, Motiwala SR, Belcher AM, van Kimmenade RRJ. A Clinical and Biomarker Scoring System to Predict the Presence of Obstructive Coronary Artery Disease. J Am Coll Cardiol. 2017 Mar 07; 69(9):1147-1156. PMID: 28254177.
    Citations: 3     Fields:    Translation:Humans
  38. Januzzi JL, Ibrahim NE. Renin-Angiotensin System Blockade in Heart Failure: More to the Picture Than Meets the Eye. J Am Coll Cardiol. 2017 02 21; 69(7):820-822. PMID: 28209223.
    Citations:    Fields:    
  39. Ibrahim NE, Desai AS, Singh JP, Januzzi JL. Advances in Heart Failure Management: Improving Outcomes With Innovation. Rev Cardiovasc Med. 2017; 18(S1):S1-S16. PMID: 28233764.
    Citations:    Fields:    
  40. Gaggin HK, Liu Y, Lyass A, van Kimmenade RR, Motiwala SR, Kelly NP, Mallick A, Gandhi PU, Ibrahim NE, Simon ML, Bhardwaj A, Belcher AM, Harisiades JE, Massaro JM, D'Agostino RB, Januzzi JL. Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography. Circulation. 2017 Jan 10; 135(2):116-127. PMID: 27881568.
    Citations: 4     Fields:    Translation:Humans
  41. Ibrahim NE, Rabideau DJ, Gaggin HK, Belcher AM, Conrad MJ, Jarolim P, Januzzi JL. Circulating Concentrations of Orexin A Predict Left Ventricular Myocardial Remodeling. J Am Coll Cardiol. 2016 11 15; 68(20):2238-2240. PMID: 27855816.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  42. Ibrahim NE, Januzzi JL. Beyond Natriuretic Peptides for Diagnosis and Management of Heart Failure. Clin Chem. 2017 Jan; 63(1):211-222. PMID: 28062619.
    Citations: 1     Fields:    Translation:Humans
  43. Gaggin HK, Belcher AM, Gandhi PU, Ibrahim NE, Januzzi JL. Serial Echocardiographic Characteristics, Novel Biomarkers and Cachexia Development in Patients with Stable Chronic Heart Failure. J Cardiovasc Transl Res. 2016 12; 9(5-6):429-431. PMID: 27631883.
    Citations: 1     Fields:    Translation:Humans
  44. Ibrahim NE, Gaggin HK, Konstam MA, Januzzi JL. Established and Emerging Roles of Biomarkers in Heart Failure Clinical Trials. Circ Heart Fail. 2016 09; 9(9). PMID: 27582282.
    Citations: 3     Fields:    Translation:Humans
  45. Ibrahim NE, Gaggin HK, Rabideau DJ, Gandhi PU, Mallick A, Januzzi JL. Worsening Renal Function during Management for Chronic Heart Failure with Reduced Ejection Fraction: Results From the Pro-BNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study. J Card Fail. 2017 Feb; 23(2):121-130. PMID: 27469482.
    Citations: 1     Fields:    Translation:Humans
  46. Mallick A, Gandhi PU, Gaggin HK, Ibrahim N, Januzzi JL. The Importance of Worsening Heart Failure in Ambulatory Patients: Definition, Characteristics, and Effects of Amino-Terminal Pro-B-Type Natriuretic Peptide Guided Therapy. JACC Heart Fail. 2016 09; 4(9):749-55. PMID: 27179830.
    Citations:    Fields:    Translation:Humans
  47. Ibrahim NE, Lopez-Candales A. Left Ventricular Outflow Tract Pseudoaneurysm Formation Following Three Aortic Valve Replacement Surgeries. Heart Views. 2015 Oct-Dec; 16(4):161-3. PMID: 26900423.
    Citations:    
  48. Ibrahim N, Januzzi JL. The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and management. Expert Rev Cardiovasc Ther. 2015; 13(9):1017-30. PMID: 26198476.
    Citations: 2     Fields:    Translation:Humans
  49. Ibrahim N, Lopez-Candales A. Cement encasement of the pericardium: echocardiographic manifestation. BMJ Case Rep. 2014 Sep 08; 2014. PMID: 25201804.
    Citations:    Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Ibrahim's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (160)
Explore
_
Co-Authors (48)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.